NCT00793403View on ClinicalTrials.gov

Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study

CompletedOBSERVATIONAL
Enrollment

293

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Rheumatoid Arthritis
Interventions
OTHER

As per routinary clinical care

As per routine clinical care

Trial Locations (1)

10128

Pfizer Investigational Site, Torino

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00793403 - Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study | Biotech Hunter | Biotech Hunter